
Glaukos Corporation GKOS
€ 122.12
0.0%
Quartalsbericht 2025-Q2
hinzugefügt 04.08.2025
Glaukos Corporation Langfristiger Schuldenstrom 2011-2026 | GKOS
Langfristiger Schuldenstrom Jährlich Glaukos Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.31 M | 430 K | 1.01 M | 1.18 M | 2.4 M | - | - | - | 8.93 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 8.93 M | 430 K | 2.54 M |
Langfristiger Schuldenstrom anderer Aktien in der Medizinische Instrumente
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
37.8 M | $ 60.38 | - | $ 12 B | ||
|
Repro Med Systems
KRMD
|
413 K | $ 3.98 | - | $ 184 M | ||
|
ICU Medical
ICUI
|
13.8 M | $ 122.99 | 0.78 % | $ 3.03 B | ||
|
iRhythm Technologies
IRTC
|
16.7 M | $ 114.16 | - | $ 3.65 B | ||
|
Intuitive Surgical
ISRG
|
39 M | $ 428.06 | - | $ 153 B | ||
|
Alcon
ALC
|
80 M | $ 64.0 | -0.03 % | $ 40.4 B | ||
|
LeMaitre Vascular
LMAT
|
2.94 M | $ 99.5 | - | $ 2.25 B | ||
|
Masimo Corporation
MASI
|
21.4 M | $ 178.35 | - | $ 9.51 B | ||
|
Ekso Bionics Holdings
EKSO
|
441 K | - | - | $ 28.6 M | ||
|
Envista Holdings Corporation
NVST
|
39 M | $ 23.86 | - | $ 4.01 B | ||
|
electroCore
ECOR
|
375 K | $ 6.43 | - | $ 54.5 K | ||
|
Haemonetics Corporation
HAE
|
8.11 M | $ 57.12 | - | $ 2.87 B | ||
|
Isoray
ISR
|
623 K | - | 0.03 % | $ 108 M | ||
|
STAAR Surgical Company
STAA
|
5.87 M | $ 32.01 | - | $ 1.59 B | ||
|
STERIS plc
STE
|
34.2 M | $ 215.98 | - | $ 21.3 B | ||
|
Teleflex Incorporated
TFX
|
100 M | $ 130.28 | - | $ 5.81 B | ||
|
InfuSystem Holdings
INFU
|
349 K | $ 8.61 | - | $ 178 M | ||
|
Microbot Medical
MBOT
|
296 K | $ 1.85 | - | $ 84.7 M | ||
|
Milestone Scientific
MLSS
|
130 K | $ 0.34 | -0.87 % | $ 27.9 M | ||
|
Merit Medical Systems
MMSI
|
10.9 M | $ 62.56 | - | $ 3.7 B | ||
|
Utah Medical Products
UTMD
|
60 K | $ 63.7 | - | $ 206 M | ||
|
West Pharmaceutical Services
WST
|
22.7 M | $ 300.19 | - | $ 21.7 B | ||
|
Pulse Biosciences
PLSE
|
1.57 M | $ 27.1 | - | $ 1.83 B | ||
|
DENTSPLY SIRONA
XRAY
|
47 M | $ 10.41 | - | $ 2.08 B | ||
|
Retractable Technologies
RVP
|
286 K | $ 0.69 | 0.01 % | $ 20.7 M | ||
|
Predictive Oncology
POAI
|
654 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
2.24 M | $ 21.06 | - | $ 1.01 B | ||
|
Stereotaxis
STXS
|
642 K | $ 1.94 | - | $ 176 M | ||
|
Baxter International
BAX
|
81 M | $ 17.78 | - | $ 9.12 B | ||
|
ResMed
RMD
|
21.9 M | $ 202.46 | - | $ 29.6 B | ||
|
AtriCure
ATRC
|
1.73 M | $ 28.15 | - | $ 1.34 B | ||
|
Harvard Bioscience
HBIO
|
1.52 M | $ 5.52 | - | $ 245 M | ||
|
NeuroMetrix
NURO
|
107 K | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
1.84 M | $ 11.03 | - | $ 451 M | ||
|
Becton, Dickinson and Company
BDX
|
135 M | $ 144.47 | - | $ 41.6 B | ||
|
Nephros
NEPH
|
386 K | $ 3.34 | - | $ 35.4 M | ||
|
OraSure Technologies
OSUR
|
2.16 M | $ 2.95 | - | $ 217 M | ||
|
Repligen Corporation
RGEN
|
21.6 M | $ 103.38 | - | $ 5.81 M |